In SH-SY5Y neuroblastoma cells, oleuropein treatment has been shown to increase the expression levels of proteins related to cell proliferation, such the p53 gene and CDK inhibitors (CDKN1A, CDKN2A and CDKN2B) [121]. The gene discussed is TP53; the disease is neuroblastoma.